Inflammation Biomarkers and Risk of All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke Cohort
Open Access
- 17 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 174 (3), 284-292
- https://doi.org/10.1093/aje/kwr085
Abstract
Inflammation biomarkers, including higher high-sensitivity C-reactive protein (hsCRP) levels, higher white blood cell (WBC) counts, and lower serum albumin levels, are associated with an increased risk of all-cause mortality. Many studies have examined these biomarkers individually, but less is known about their joint association with mortality. hsCRP, WBC count, and serum albumin were measured at baseline in the Reasons for Geographic and Racial Differences in Stroke Study cohort members, who were enrolled in 2003–2007. Over 4.5 years, there were 1,062 deaths in 17,845 participants. High-risk categories were defined as hsCRP or WBC levels above the 75th percentile (5.1 mg/L and 6.9 × 109 cells/L, respectively) and albumin levels below the 25th percentile (4.00 g/dL). The authors derived 4 groups that corresponded to 0 (n = 8,341), 1 (n = 6,277), 2 (n = 2,635), or 3 (n = 592) biomarkers in the high-risk category. After adjustment for age, sex, waist circumference, race, region, smoking, alcohol use, income, educational level, physical activity frequency, and medical history and compared with those with no biomarkers in the high-risk category, the hazard ratios for all-cause mortality for 1, 2, and 3 biomarkers in the high-risk category were 1.56 (95% confidence interval: 1.33, 1.82), 2.19 (95% confidence interval: 1.84, 2.62), and 2.96 (95% confidence interval: 2.30, 3.80), respectively (Ptrend < 0.0001). Adding the 3 inflammation biomarkers to a fully adjusted model improved risk discrimination by 23.7% (95% confidence interval: 9.3, 39.9). Measurement of more than 1 biomarker is more useful in risk prediction than single biomarkers.Keywords
This publication has 24 references indexed in Scilit:
- Prevalence of Neutropenia in the U.S. Population: Age, Sex, Smoking Status, and Ethnic DifferencesAnnals of Internal Medicine, 2007
- Inflammation Biomarkers and Near-Term Death in Older MenAmerican Journal of Epidemiology, 2007
- Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohortAmerican Heart Journal, 2006
- The association of markers of inflammation with weight change in older adults: the Cardiovascular Health StudyInternational Journal of Obesity, 2006
- Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?The American Journal of Cardiology, 2006
- The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and DesignNeuroepidemiology, 2005
- Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal WomenArchives of Internal Medicine, 2005
- Leukocyte Count in Vascular Risk PredictionArchives of Internal Medicine, 2005
- Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart DiseaseJAMA, 1998
- Body Size and Fat Distribution as Predictors of Coronary Heart Disease among Middle-aged and Older US MenAmerican Journal of Epidemiology, 1995